Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 7, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TEL | TE CONNECTIVITY PLC | NYSE | Electronic Components | A | $63.36B | $215.91 | 3.46% | $4.47B | 30.89x | 0.96 | Switzerland | 40 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $43.35B | $328.16 | -0.93% | $151.92M | 1,058.58x | 19.74 | United States | 43 |
| LVS | LAS VEGAS SANDS CORP | NYSE | Resorts & Casinos | A | $38.84B | $57.80 | 1.51% | $4.18B | 24.60x | 12.57 | United States | 38 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.08B | $141.20 | 2.37% | $679.20M | 32.76x | 0.42 | United States | 62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.06B | $165.50 | 1.44% | $182.64M | -27.63x | 1.87 | Ireland | 16 |
| PEGA | PEGASYSTEMS INC | NASDAQ | Software - Application | A | $6.81B | $40.12 | 5.03% | $373.32M | 24.77x | 1.17 | United States | 50 |
| VISN | VISTANCE NETWORKS INC | NASDAQ | Communication Equipment | A | $4.21B | $19.00 | 7.22% | $1.70B | 4.63x | -3.84 | United States | 24 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $4.05B | $17.67 | 5.37% | -$33.04M | 53.55x | 2.40 | United States | 50 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $2.86B | $36.19 | 3.82% | $57.00M | 92.79x | 0.09 | United States | 45 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.12B | $163.29 | 1.73% | $301.16M | 9.46x | 1.82 | United States | 50 |
| HLMN | HILLMAN SOLUTIONS CORP | NASDAQ | Tools & Accessories | A | $2.07B | $10.48 | -0.57% | $249.21M | 52.40x | 0.95 | United States | 41 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $1.34B | $17.08 | 6.68% | $127.81M | 40.67x | 1.28 | United States | 58 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.28B | $48.29 | 1.75% | $119.00M | 43.50x | 0.93 | United States | 35 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.04B | $3.60 | -0.83% | $137.29M | 45.00x | 0.68 | United States | 41 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $889.43M | $31.71 | 0.22% | $174.52M | 7.24x | 5.24 | United States | 39 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $766.40M | $10.54 | 2.33% | $98.00M | 10.87x | 0.23 | United States | 51 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $670.58M | $17.97 | 1.64% | $145.14M | N/A | 6.80 | Mexico | 27 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $549.61M | $17.99 | 6.89% | $86.84M | 48.62x | 2.69 | United States | 31 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $478.46M | $3.77 | 1.62% | $18.04M | -31.42x | 0.49 | United States | 20 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $245.30M | $6.18 | 6.19% | -$4.74M | -26.87x | 0.64 | United States | 17 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $242.79M | $29.11 | 0.38% | $12.05M | 30.01x | 0.20 | United States | 51 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $203.00M | $10.89 | 3.32% | $11.65M | N/A | 0.39 | United States | 26 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $157.00M | $7.72 | 1.98% | $24.16M | 29.69x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.